Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Harvard Business School
Farmers Insurance
Chinese Patent Office
Citi
Queensland Health
Cantor Fitzgerald
Federal Trade Commission

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,860,946

« Back to Dashboard

Summary for Patent: 5,860,946
Title: Instrument for inserting a suppository
Abstract:In an instrument for inserting a suppository, which instrument comprises a tubular housing (31) with a first end adapted to receive said suppository between two tongues (30) and a second end through which a plunger (22) is inserted in the tube, which plunger has a first end having a circular cross section and two axially spaced circumferential flanges (26, 27) and a second end projecting from the second end of the tube (31). The first end of the tube has an inwardly extending shoulder (25) which engage between said flanges (26, 27) and the first end of the piston is by radial slots divided into an uneven number of sectors (29). The plunger (22) has between its first end and a press button (24) at its second end angular spaced radial walls (21) abutting the inner wall of the tube (31) and axial spaced disc shaped walls are provided having a diameter corresponding to the inner diameter of the tube (31).
Inventor(s): Hofstatter; Thibaud (Helsing.o slashed.r, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:08/886,588
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,860,946
Patent Claim Types:
see list of patent claims
Dosage form;

Drugs Protected by US Patent 5,860,946

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,860,946

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark0752/96Jul 05, 1996

International Family Members for US Patent 5,860,946

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 240764 ➤ Try a Free Trial
Australia 3254397 ➤ Try a Free Trial
Canada 2258310 ➤ Try a Free Trial
Germany 69722203 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Chinese Patent Office
Moodys
Teva
Accenture
Fish and Richardson
Citi
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.